Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532252) titled 'Daridorexant for Alcohol Use Disorder' on April 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Johns Hopkins University

Condition: Daridorexant Placebo - Control

Intervention: Drug: Daridorexant 50 mg

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 1, 2027

Target Sample Size: 150

To know more, visit https://clinicaltrials.gov/study/NCT07532252

Disclaimer: Curated by HT Syndicatio...